Announce Date | 05/06/2025 |
EPS Normalized Actual | $2.15 (Beat by $0.56) |
EPS GAAP Actual | $2.15 (Beat by $0.56) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 13.24652 | 5.47 | 12.47845 | 14.55875 | 3 |
Dec 2027 | 11.6532 | 6.21 | 11.31306 | 12.06517 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.45 | 1.45 | 0B | -INF% | 0M |
FQ4 2024 (Dec 2024) | 0.8 | 0.8 | 1.967B | 7.52% | 1967M |
FQ3 2024 (Sep 2024) | 1 | 1 | 1.828B | 0.27% | 1828M |
FQ2 2024 (Jun 2024) | 2.05 | 2.05 | 1.821B | 5.22% | 1821M |
FQ1 2024 (Mar 2024) | 2.46 | 2.46 | 2.051B | 14.38% | 2051M |
FQ4 2023 (Dec 2023) | 1.14 | 1.14 | 1.819B | 12.53% | 1819M |
FQ3 2023 (Sep 2023) | 2.35 | 2.35 | 1.823B | 26.6% | 1823M |
FQ2 2023 (Jun 2023) | 1.5 | 1.5 | 1.726B | 11.99% | 1726M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Sep 2028) | 3.47151 | -- | 3.30824 | 3.80357 | 10 |
FQ2 2028 (Jun 2028) | 3.3917 | -- | 3.23218 | 3.71613 | 7 |
FQ1 2028 (Mar 2028) | 2.93576 | -- | 2.79769 | 3.21657 | 5 |
FQ4 2027 (Oct 2027) | 3.0556 | -- | 3.0556 | 3.0556 | 4 |
FQ3 2027 (Jul 2027) | 3.039 | -- | 3.039 | 3.039 | 3 |
FQ2 2027 (Jun 2027) | 3.039 | -- | 3.00173 | 3.06299 | 8 |
FQ1 2027 (Mar 2027) | 2.5535 | -- | 2.52219 | 2.57366 | 8 |
FQ4 2026 (Oct 2026) | 2.68645 | -- | 2.46113 | 2.85153 | 3 |
FQ3 2026 (Jul 2026) | 2.7091 | -- | 2.48188 | 2.87557 | 3 |
FQ2 2026 (Jun 2026) | 2.78 | -- | 2.62353 | 2.88125 | 3 |
FQ1 2026 (Mar 2026) | 2.1312 | 31.96 | 1.95245 | 2.26216 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Sep 2028) | 2.17B | -- | 2.09B | 2.33B | 1 |
FQ2 2028 (Jun 2028) | 2.16B | -- | 2.08B | 2.32B | 1 |
FQ1 2028 (Mar 2028) | 2.16B | -- | 2.08B | 2.32B | 1 |
FQ4 2027 (Oct 2027) | 2.15B | -- | 2.15B | 2.15B | 2 |
FQ3 2027 (Jul 2027) | 2.14B | -- | 2.14B | 2.14B | 2 |
FQ2 2027 (Jun 2027) | 2.14B | -- | 2.12B | 2.16B | 1 |
FQ1 2027 (Mar 2027) | 2.13B | -- | 2.11B | 2.14B | 1 |
FQ4 2026 (Oct 2026) | 2.06B | -- | 1.92B | 2.15B | 2 |
FQ3 2026 (Jul 2026) | 2.03B | -- | 1.9B | 2.13B | 2 |
FQ2 2026 (Jun 2026) | 2.01B | -- | 1.93B | 2.07B | 1 |
FQ1 2026 (Mar 2026) | 2.01B | -- | 1.88B | 2.11B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.45 | 1.45 | 100% | |
FQ4 2024 (Dec 2024) | 0.8 | 0.8 | 100% | |
FQ3 2024 (Sep 2024) | 1 | 1 | 100% | |
FQ2 2024 (Jun 2024) | 2.05 | 2.05 | 100% | |
FQ1 2024 (Mar 2024) | 2.46 | 2.46 | 100% | |
FQ4 2023 (Dec 2023) | 1.14 | 1.14 | 100% | |
FQ3 2023 (Sep 2023) | 2.35 | 2.35 | 100% | |
FQ2 2023 (Jun 2023) | 1.5 | 1.5 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
FQ4 2024 (Dec 2024) | $0B | $1.97B | $1967M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.83B | $1828M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.82B | $1821M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.05B | $2051M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.82B | $1819M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.82B | $1823M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.73B | $1726M | 100% |